skip to main content

News Archive

Date: 06/23/2017
As thyroid cancer rates rise, more people are having surgery to remove all or part of their thyroid. A new study suggests complications from these procedures are more common than previously believed.
Date: 06/21/2017
About 39,300 cancer professionals from around the world met June 2-6 in Chicago for the American Society of Clinical Oncology Annual Meeting.
Date: 06/05/2017
Nearly three dozen U-M Cancer Center faculty and trainees will be presenting oral abstracts or posters, leading discussion of new research or chairing sessions during the ASCO annual meeting, June 2-6. Schedule of U-M Presentations at ASCO for June 6:
Date: 06/05/2017
In a dramatic shift since the publication of margin guidelines for breast cancer surgery, lumpectomy rates have substantially increased and more-aggressive surgical options have been used less often, a new study finds.
Date: 06/04/2017
Nearly three dozen U-M Cancer Center faculty and trainees will be presenting oral abstracts or posters, leading discussion of new research or chairing sessions during the ASCO annual meeting, June 2-6. Schedule for June 5:
Date: 06/03/2017
Nearly three dozen U-M Cancer Center faculty and trainees will be presenting oral abstracts or posters, leading discussion of new research or chairing sessions during the ASCO annual meeting, June 2-6.
Date: 06/03/2017
A new analysis finds that nearly three-quarters of 500 patients with advanced cancer could be referred to a potential targeted treatment based on the results of a comprehensive analysis of their tumor’s genetic landscape.
Date: 06/02/2017
Nearly three dozen U-M Cancer Center faculty and trainees will be presenting oral abstracts or posters, leading discussion of new research or chairing sessions during the ASCO annual meeting, June 2-6.
Date: 06/01/2017
Dozens of U-M Cancer Center faculty are presenting oral abstracts and posters during the annual ASCO conference.
Date: 06/01/2017
Daniel Hayes, M.D., Clinical Director of the Breast Oncology Program in the University of Michigan Comprehensive Cancer Center, discusses the results of trials involving the use of anti-estrogen therapy for more than five years for breast cancer patients.

Pages